Teligent Says Stalled Plan Talks Make Liquidation Best Option

Bankrupt generic pharmaceutical company Teligent Inc. told a Delaware bankruptcy judge that an impasse in talks on a restructuring plan and the expiration of its permission to use cash collateral have...

Already a subscriber? Click here to view full article